- Post-Effective Amendment to an S-8 filing (S-8 POS)

Registration No. 333-151579

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

Post-Effective Amendment No. 1

to

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

MedCath Corporation

(Exact name of Registrant as specified in its Charter)

 

 

 

Delaware		56-2248952
(State or other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)
10720 Sikes Place, Suite 200 Charlotte, North Carolina		28277
(Address of principal executive offices)		(Zip Code)

 

 

Amended and Restated Outside Directors’ Stock Option Plan, as amended

(Full title of the Plan)

 

 

James A. Parker

President and Chief Executive Officer

MedCath Corporation

10720 Sikes Place, Suite 200

Charlotte, North Carolina 28277

(Name and Address of Agent for Service)

[phone]

(Telephone number, Including Area Code, of Agent for Service)

Copy to:

Hal Levinson

Moore & Van Allen PLLC

100 North Tryon Street, Suite 4700

Charlotte, North Carolina 28202-4003

[phone]

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer		¨		Accelerated filer		x
Non-accelerated filer		¨ (Do not check if a smaller reporting company)		Smaller reporting company		¨

 

 

 

---

EXPLANATORY NOTE

This Post-Effective Amendment No. 1 (the “Post-Effective Amendment”) to Registration Statement on Form S-8, No. 333-151579 (the “Registration Statement”) of MedCath Corporation (the “Company” or the “Registrant”) is being filed to terminate the effectiveness of the Registration Statement and to deregister 65,700 unsold shares reserved for issuance and registered for sale under the Amended and Restated Outside Directors’ Stock Option Plan, as amended (the “Plan”). The Plan has been terminated by the Company’s Board of Directors and all stock options granted thereunder or governed thereby have either been exercised, expired unexercised or cancelled. The Registrant is filing this Post-Effective Amendment in accordance with the undertaking in the Registration Statement to terminate the effectiveness of the Registration Statement and to remove from registration all securities that remain unsold at the termination of the offering through the Plan.

---

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Charlotte, State of North Carolina, on August 28, 2012.

 

MEDCATH CORPORATION
By:		/s/ J AMES A. P ARKER
		James A. Parker     President and Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities indicated on the dates indicated.

 

Signature		Title		Date
/ S /    J AMES A P ARKER         James A. Parker		President, Chief Executive Officer and Director ( Principal Executive Officer )		August 28, 2012
/ S /    L ORA R AMSEY         Lora Ramsey		Vice President and Chief Financial Officer ( Principal Financial Officer )		August 28, 2012
/ S /    W OODRIN G ROSSMAN         Woodrin Grossman		Director		August 28, 2012
/ S /    J OHN T. C ASEY          John T. Casey		Director		August 28, 2012
/ S /    J ACQUE J. S OKOLOV         Jacque J. Sokolov, Md		Director		August 28, 2012
/ S /    P AMELA G. B AILEY         Pamela G. Bailey		Director		August 28, 2012
/ S /    R OBERT S. M C C OY , J R .         Robert S. McCoy, Jr.		Director		August 28, 2012
/ S /    J AMES A. D EAL         James A. Deal		Director		August 28, 2012